Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT07182435
What this trial is testing

Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor Malignancies
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 36
Early research (Phase 1)Study completedNCT00676949
What this trial is testing

Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors

Who this might be right for
Metastatic Tumors
Kyushu University 18
Early research (Phase 1)Study completedNCT05105048
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647

Who this might be right for
Cytomegalovirus Infection
ModernaTX, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00513526
What this trial is testing

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Who this might be right for
InfectionPrecancerous Condition
AIDS Malignancy Consortium 112
Large-scale testing (Phase 3)Not Yet RecruitingNCT07345208
What this trial is testing

Safety and Immunogenicity of ID vs IM Rabies Vaccine

Who this might be right for
Rabies
International Centre for Diarrhoeal Disease Research, Bangladesh 90
Early research (Phase 1)Study completedNCT00000749
What this trial is testing

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 14
Early research (Phase 1)Study completedNCT01403155
What this trial is testing

A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001

Who this might be right for
Healthy
Inovio Pharmaceuticals 22
Early research (Phase 1)Study completedNCT02603055
What this trial is testing

A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults

Who this might be right for
Hepatitis E
Jiangsu Province Centers for Disease Control and Prevention 60
Early research (Phase 1)Study completedNCT00000884
What this trial is testing

Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 84
Testing effectiveness (Phase 2)Study completedNCT03685708
What this trial is testing

HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
HepatitisSafety and Tolerability
National Heart, Lung, and Blood Institute (NHLBI) 78
Early research (Phase 1)Study completedNCT05163847
What this trial is testing

Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

Who this might be right for
Influenza Vaccine
FluGen Inc 303
Testing effectiveness (Phase 2)Active Not RecruitingNCT04270838
What this trial is testing

A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Who this might be right for
Rabies
University of Oxford 174
Large-scale testing (Phase 3)Study completedNCT00751348
What this trial is testing

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

Who this might be right for
MeaslesVaricellaMumps+1 more
GlaxoSmithKline 475
Large-scale testing (Phase 3)Study completedNCT03450915
What this trial is testing

A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine

Who this might be right for
Influenza
BiondVax Pharmaceuticals ltd. 12,460
Testing effectiveness (Phase 2)Looking for participantsNCT07215858
What this trial is testing

BPL-1357 Against H1N1 Influenza Virus Challenge

Who this might be right for
InfluenzaHuman
National Institute of Allergy and Infectious Diseases (NIAID) 129
Testing effectiveness (Phase 2)Study completedNCT03541499
What this trial is testing

Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults

Who this might be right for
PertussisPertussis Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT00746798
What this trial is testing

Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults

Who this might be right for
West Nile Fever
Sanofi Pasteur, a Sanofi Company 479
Large-scale testing (Phase 3)Active Not RecruitingNCT07047521
What this trial is testing

A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

Who this might be right for
Dengue Fever
Takeda 496
Large-scale testing (Phase 3)Study completedNCT05021016
What this trial is testing

Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

Who this might be right for
Covid19
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 150
Early research (Phase 1)Study completedNCT00487916
What this trial is testing

Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium Falciparum

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation